Xiangyong Hao
- Molecular Biology top 10%
- Cancer Research top 5%
- Surgery
- Oncology
- Hepatology top 10%
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (9 papers)Liver Disease Diagnosis and Treatment (6 papers)Cancer Mechanisms and Therapy (5 papers)
- Journals
- SHILAP Revista de lepidopterologíaCancer ResearchCochrane Database of Systematic Reviews
- Partner nations
- China
In The Last Decade
Xiangyong Hao
34 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Molecular Biology 719
- Cancer Research 547
- Surgery 147
- Oncology 139
- Hepatology 87
Countries citing papers authored by Xiangyong Hao
This map shows the geographic impact of Xiangyong Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyong Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyong Hao more than expected).
Fields of papers citing papers by Xiangyong Hao
This network shows the impact of papers produced by Xiangyong Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyong Hao. The network helps show where Xiangyong Hao may publish in the future.
Co-authorship network of co-authors of Xiangyong Hao
This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyong Hao. A scholar is included among the top collaborators of Xiangyong Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyong Hao. Xiangyong Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 12 | |
| 4 | 3 | |
| 5 | 5 | |
| 6 | 8 | |
| 7 | 12 | |
| 8 | 20 | |
| 9 | 6 | |
| 10 | 12 | |
| 11 | 7 | |
| 12 | 29 | |
| 13 | 14 | |
| 14 | 17 | |
| 15 | 148 | |
| 16 | 20 | |
| 17 | KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3breakdown → | 349 |
| 18 | 22 | |
| 19 | 40 | |
| 20 | 28 |
About Xiangyong Hao
Xiangyong Hao is a scholar working on Hepatology, Cancer Research and Pharmacy, having authored 35 papers that have together received 1.0k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Liver Disease Diagnosis and Treatment (6 papers) and Cancer Mechanisms and Therapy (5 papers). The work is most often cited by research in Cancer Research (547 citations), Hepatology (87 citations) and Molecular Biology (719 citations). Xiangyong Hao has collaborated with scholars based in China. Frequent co-authors include Kefei Yuan, Xiaokai Yan, Hong Wu, Lin Xu, Yong Zeng, Haotian Liao, Jiaxin Li, Tian Lan, Xi Chen and Mingheng Liao. Their work appears in journals such as SHILAP Revista de lepidopterología, Cancer Research and Cochrane Database of Systematic Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.